Close Menu

Exagen Diagnostics

The financing will go toward ongoing commercialization of the firm's autoimmune tests and therapeutics promotion business.

The partners will conduct an exploratory study to determine how the results of Exagen's lupus test impacts primary care physician practice referral patterns.

The company said that it will use the funds to accelerate the commercialization of its proprietary Cell Bound Complement Activation Products technology.